News at Columbia SPS Category - Any -AlumniFacultyImpacts and InsightsIn the CommunityIn the MediaKnowledge BaseOffice of the DeanPress ReleaseResearch & PublicationsSchoolStaffStudent Faculty ALP Faculty Speak in France ALP Faculty spoke at a recent conference in France about how to improve ESL fluency in the classroom. Faculty Robert Klitzman on the Risks of Becoming the Next Henrietta Lacks Robert Klitzman asks whether patients should be concerned that their matter could be used for science without their consent. Faculty New Community Speaker Series Launches in West Harlem EPIC has worked to continually expand its portfolio of activities and in 2017 launched its first Speakers Series. Faculty New Robert Klitzman Bioethics Paper on IVF Ethical challenges faced by IVF providers in BMC Medical Ethics Faculty The Secret to President Donald Trump's Success: Blame Klitzman shows how President Trump was able to rise as an inexperienced politician, due to his way with narrative. Faculty Nobel Peace Prize Laureate to Direct Columbia's Women, Peace, and Security Initative The new Columbia initiative for Women, Peace, and Security will have extraordinary leadership Faculty What Is the Future of Strategic Communication? Jesse Scinto is taking on a new role as the Associate Director for Curriculum Development. Faculty Spring 2017 Narrative Medicine Rounds Feature Bestselling Authors and New Yorker Staff Writers The Spring 2017 Narrative Medicine Rounds includes Dr. Lucy Kalanithi and New Yorker staff writer Rachel Aviv. Faculty Corey Hirsch to Present at Cyber Warfare Conference Dr. Corey Hirsch has been selected to present a paper in Washington, D.C. about the collateral damage risks of cyber weapons. Faculty What is a Knowledge-Driven Digital Product Innovation? Information and Knowledge Strategy leadership is both intrapreneurial and entrepreneurial. Faculty Can a Baby Have Three Parents? Bioethicist Dr. Klitzman is featured in The New York Times, responding to the first genetic "three-parent" baby. Faculty Robert Klitzman on EpiPen's Price Hike How can drug companies get away with such outrageous prices for live-saving medicine, like the EpiPen? Load More
